Researchers have identified an important signaling pathway that, when blocked, significantly decreases the spread of pediatric bone cancer. Researchers have identified an important signaling pathway ...

Investigators have found a known genetic pathway to be active in many difficult-to-treat pediatric brain tumors called low-grade gliomas, potentially offering a new target for the treatment of these ...

Please provide your email address to receive an email when new articles are posted on . Investigators at The University of Texas MD Anderson Children’s Cancer Hospital found that blocking the Notch ...

(HealthDay News) — Implementation of a clinical pathway to improve care of acute gastroenteritis (AGE) patients is associated with a sustained reduction in intravenous (IV) fluid use and length of ...

Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness of standard chemotherapies for a highly aggressive type of ...

Reducing Medicare Part D Out-of-Pocket Costs for Specialty Oral Anticancer Drugs Under the Inflation Reduction Act: Highlighting the Benefits of Enrolling in the Medicare Prescription Payment Plan ...

New pathway identified as a target for precision medicine against a common pediatric brain tumor as research discovered the causal mechanism behind the tumor. This discovery raises hopes for ...

Investigators at Johns Hopkins have found a known genetic pathway to be active in many difficult-to-treat pediatric brain tumors called low-grade gliomas, potentially offering a new target for the ...

In laboratory studies, researchers found that the pathway, called mammalian target of rapamycin (mTOR), was highly active in pediatric low-grade gliomas, and that mTOR activity could be blocked using ...